跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Orastin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Orastin
Approved
STANDARD
Orastin
The ACME Laboratories Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
2a75ea30979927ea
Company
The ACME Laboratories Inc.
Type
Standard
Approval Details
Approval Id
2a75ea30979927ea
Drug Approval Philippines Name
Orastin
Product Name
Orastin
Registration Number
DRP-587-03
Brand Name
Orastin
Generic Name
Nystatin
Dosage Form
Oral suspension
Dosage Strength
100,000 I.U./mL
Manufacturer
The ACME Laboratories Inc.
Importer
Euro Generics International Phils., Inc.
Distributor
Euro Generics International Phils., Inc.
Issuance Date
29 May 2023
Expiry Date
29 August 2028
Pharmacologic Category
Antifungal
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
2a75ea30979927ea
Type
Standard
Back to Philippines FDA Approvals